Funding and Research Opportunities

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

Notices

Revised: Notice of NIH's Interest in Diversity
(NOT-OD-18-129) National Institutes of Health

Grant Application Due Dates Folowing the Receipt Lapse in Appropriations
(NOT-OD-18-131) National Institutes of Health

Notice of Correction to PA-18-517, "Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp - Clinical Trial Not Allowed)"
(NOT-CA-18-035)
National Cancer Institute

Request for Information (RFI): Strategically Critical Resources or Infrastructures Recommended for NHLBI Support Using the R24/U24 Grant Mechanisms
(NOT-HL-17-571)
National Heart, Lung, and Blood Institute

Notice of Correction of Key Dates for PAR-17-004 " Secondary Analyses of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21)"
(NOT-HL-18-583)
National Heart, Lung, and Blood Institute

Notice of Expiration of RFA-HL-17-012 "Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood, and Sleep Technologies with Small Commercial Markets (R44)"
(NOT-HL-18-584)
National Heart, Lung, and Blood Institute

NHLBI Announces Webinar for PAR-18-577, New Epidemiology Cohort Studies in Heart, Lung, Blood, and Sleep Diseases and Disorders (U01 - Clinical Trial Not Allowed)
(NOT-HL-18-587)
National Heart, Lung, and Blood Institute

Requests for Applications

The Human BioMolecular Atlas Program (HuBMAP) Integration, Visualization and Engagement (HIVE) Initiative (OT2 Clinical Trials Not Allowed)
(RFA-RM-18-001)
The Common Fund/Office of Strategic Coordination

Rodent Testing Centers for Development of Reporter Systems and Evaluation of Somatic Cell Genome Editing Tools (U42 Clinical Trial Not Allowed)
(RFA-RM-18-012)
The Common Fund/Office of Strategic Coordination

Development of Large Animal Reporter Systems for Testing Somatic Cell Genome Editing Tools (U24 Clinical Trial Not Allowed)
(RFA-RM-18-013)
The Common Fund/Office of Strategic Coordination

Development of Cell and Tissue Platforms to Detect Adverse Biological Consequences of Somatic Cell Gene Editing (U01 Clinical Trial Not Allowed)
(RFA-RM-18-015)
The Common Fund/Office of Strategic Coordination

Innovative Technologies to Deliver Genome Editing Machinery to Disease-relevant Cells and Tissues (UG3/UH3 Clinical Trial Not Allowed)
(RFA-RM-18-016)
The Common Fund/Office of Strategic Coordination

Expanding the Human Genome Editing Repertoire (U01 Clinical Trial Not Allowed)
(RFA-RM-18-017)
The Common Fund/Office of Strategic Coordination

Somatic Cell Genome Editing Dissemination and Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-RM-18-018)
The Common Fund/Office of Strategic Coordination

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
(PA-18-586)
National Heart, Lung, and Blood Institute

Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
(PA-18-589)
National Heart, Lung, and Blood Institute

Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)
(PA-18-590)
National Heart, Lung, and Blood Institute

Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional)
(PA-18-591)
National Heart, Lung, and Blood Institute

Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed )
(PA-18-592)
National Institutes of Health

Program Announcements

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
(PA-18-586)
National Heart, Lung, and Blood Institute

Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
(PA-18-589)
National Heart, Lung, and Blood Institute

Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)
(PA-18-590)
National Heart, Lung, and Blood Institute

Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional)
(PA-18-591)
National Heart, Lung, and Blood Institute

Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed )
(PA-18-592)
National Institutes of Health